Status:
COMPLETED
Prevention of Cow's Milk Allergy in Children
Lead Sponsor:
Bledina
Collaborating Sponsors:
Optimed Medizinische Instrumente GmbH
Conditions:
Milk Hypersensitivity
Eligibility:
All Genders
Phase:
NA
Brief Summary
Impact of fermented milk in prevention of cow's milk allergy in new born and infants
Eligibility Criteria
Inclusion
- mother before the 5th month of pregnancy
- mother agreeing to stop consumption of yogurts and fermented milks during the 3rd quarter of pregnancy
- mother agreeing to receive a calcium supplementation during the 3rd quarter of pregnancy
- atopic mother or father and at least another atopic member (sister or brother)
- parents having given written informed consent
- adhesion to eviction regimen for mother and child
- parents agreeing with a regular follow-up (3 visits and monthly phone call with the dietician)
Exclusion
- mother in an exclusion period from another study
- parents refusing to sign the informed consent
- infant in a situation which could interfere with an optimal participation to the study, or which could represent a risk for the infant, according to the investigator
- known or suspected immunodeficiency in the family
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
142 Patients enrolled
Trial Details
Trial ID
NCT00792090
Start Date
November 1 2003
End Date
July 1 2008
Last Update
November 17 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital central
Nancy, France, 57000
2
Hôpital Saint Vincent de Paul
Paris, France, 75014